Clinical Trial Update: A Study of the Systemic Absorption of MOB015B [Phase 1]

View source ↗

Summary

Phase 1 study assessing the systemic absorption of MOB015B in onychomycosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• MOB015B (MOB015B)

Snippet

Sponsor: Moberg Pharma AB | Conditions: Onychomycosis | Phase 1 | Status: COMPLETED